bpc-157 wikipedia BPC 157 (Body Protection Compound-157)

10.1016/j.ijpharm.2009.06.019 83 MontegioveN.CalzoniE.EmilianiC.CesarettiA

In fact, some trials observed slight improvements in metabolic markers, likely secondary to fat loss rather than direct peptide effects

At the same time, if verified peptide formulations were ultimately shown to enhance soft-tissue recovery without increasing infection risk, the clinical relevance for TJA would be substantial, underscoring the importance of rigorous clinical investigation rather than informal adoption

As a result, VEGF has long been recognized as a potent marker of invasive cancer, and inhibiting VEGF signaling can prevent tumor progression and development